PPARG and type 2 diabetes mellitus: In fact, some of the established T2D-associated genes are already known drug targets, for example, PPARG and thiazolidinediones (TZDs), a drug class used to treat T2D by activating PPARs [11] and KCNJ11 and sulfonylureas [12, 49].